These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34319275)

  • 21. Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis.
    Black CJ; Yuan Y; Selinger CP; Camilleri M; Quigley EMM; Moayyedi P; Ford AC
    Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):117-131. PubMed ID: 31859183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of aromatherapy massage with lemon and peppermint essential oil on menopausal symptoms: A double-blinded, randomized placebo controlled clinical trial.
    Döner Şİ; Dağ Tüzmen H; Duran B; Sunar F
    Explore (NY); 2024; 20(3):313-318. PubMed ID: 37743153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does propolis affect the quality of life and complications in subjects with irritable bowel syndrome (diagnosed with Rome IV criteria)? A study protocol of the randomized, double-blinded, placebo-controlled clinical trial.
    Miryan M; Alavinejad P; Abbaspour M; Soleimani D; Ostadrahimi A
    Trials; 2020 Aug; 21(1):698. PubMed ID: 32758282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic Effect of Chang'an I Recipe ( I ) on Irritable Bowel Syndrome with Diarrhea: A Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial.
    Tang XD; Lu B; Li ZH; Wei W; Meng LN; Li BS; Tang ZP; Gao R; Wang FY; Lu F; Bian LQ; Zhao YP; Wang P; Zhang YQ
    Chin J Integr Med; 2018 Sep; 24(9):645-652. PubMed ID: 27487786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis.
    Ford AC; Talley NJ; Spiegel BM; Foxx-Orenstein AE; Schiller L; Quigley EM; Moayyedi P
    BMJ; 2008 Nov; 337():a2313. PubMed ID: 19008265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.
    Chey WD; Lembo AJ; Lavins BJ; Shiff SJ; Kurtz CB; Currie MG; MacDougall JE; Jia XD; Shao JZ; Fitch DA; Baird MJ; Schneier HA; Johnston JM
    Am J Gastroenterol; 2012 Nov; 107(11):1702-12. PubMed ID: 22986437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome.
    Zhou Q; Verne ML; Fields JZ; Lefante JJ; Basra S; Salameh H; Verne GN
    Gut; 2019 Jun; 68(6):996-1002. PubMed ID: 30108163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial.
    Tang XD; Zhang SS; Hou XH; Li ZH; Chen SN; Feng PM; Yang XN; Li HZ; Wu JQ; Xia PJ; Yang XJ; Zhou HJ; Wang HY; Ai YW; Li K
    Chin J Integr Med; 2019 Dec; 25(12):887-894. PubMed ID: 31292845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders.
    Chumpitazi BP; Kearns GL; Shulman RJ
    Aliment Pharmacol Ther; 2018 Mar; 47(6):738-752. PubMed ID: 29372567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Benefit and Tolerability of IQP-CL-101 (Xanthofen) in the Symptomatic Improvement of Irritable Bowel Syndrome: A Double-Blinded, Randomised, Placebo-Controlled Clinical Trial.
    Alt F; Chong PW; Teng E; Uebelhack R
    Phytother Res; 2017 Jul; 31(7):1056-1062. PubMed ID: 28508427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of Xiang-Sha-Liu-Jun-Zi tang (XSLJZT) on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial.
    Shih YS; Tsai CH; Li TC; Lai HC; Wang KT; Liao WL; Hsieh CL
    J Ethnopharmacol; 2019 Jun; 238():111889. PubMed ID: 31009707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peppermint oil.
    Kligler B; Chaudhary S
    Am Fam Physician; 2007 Apr; 75(7):1027-30. PubMed ID: 17427617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome.
    Saito YA; Almazar AE; Tilkes KE; Choung RS; Van Norstrand MD; Schleck CD; Zinsmeister AR; Talley NJ
    Aliment Pharmacol Ther; 2019 Feb; 49(4):389-397. PubMed ID: 30663077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial.
    Johnsen PH; Hilpüsch F; Cavanagh JP; Leikanger IS; Kolstad C; Valle PC; Goll R
    Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):17-24. PubMed ID: 29100842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of peppermint oil for the treatment in Japanese patients with irritable bowel syndrome: a prospective, open-label, and single-arm study.
    Matsueda K; Fukudo S; Ogishima M; Naito Y; Nakamura S
    Biopsychosoc Med; 2024 Feb; 18(1):3. PubMed ID: 38331851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial.
    Aroniadis OC; Brandt LJ; Oneto C; Feuerstadt P; Sherman A; Wolkoff AW; Kassam Z; Sadovsky RG; Elliott RJ; Budree S; Kim M; Keller MJ
    Lancet Gastroenterol Hepatol; 2019 Sep; 4(9):675-685. PubMed ID: 31326345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome.
    Saito YA; Rey E; Almazar-Elder AE; Harmsen WS; Zinsmeister AR; Locke GR; Talley NJ
    Am J Gastroenterol; 2010 Jan; 105(1):170-7. PubMed ID: 19809408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of individualized homeopathic medicines in irritable bowel syndrome: A double-blind randomized, placebo-controlled trial.
    Das AD; Ghosh S; Palanisamy C; Guha N; Mandal S; Maiti S; Nath A; Singh NK; Koley M; Saha S
    Explore (NY); 2023; 19(4):519-527. PubMed ID: 36307315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.